Testing inflammation markers in psoriasis with and without joint symptoms
Treatments studied
Part of Bones, joints & muscles, Skin clinical trials.
This study looks at how inflammatory “cytokines” are expressed in people with psoriasis—both those with joint involvement and those without. It may help researchers understand what drives joint disease and guide better future monitoring or treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have signed consent to join the study
- Have psoriasis for at least 5 years and at least one skin patch larger than 2 cm
- For the skin-only group: have no joint symptoms and normal ultrasound of joints and entheses (tendon/ligament attachment areas)
- For the joint group: meet criteria for psoriatic arthritis and have at least one area of active joint inflammation on exam
- Do not take DMARDs or blood thinners, and do not have a bleeding/clotting disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with early arthritis related to rheumatoid arthritis, psoriatic arthritis, or psoriasis. Researchers want to understand how these early conditions behave and may help guide better treatment decisions.
This study looks at how atopic dermatitis (eczema), psoriasis, or other autoimmune skin diseases change over time and how the body responds to anti-inflammatory signals. Your information and—if eligible—samples help researchers find patterns that could guide better treatments.
This study tests whether a personalized treatment plan can help people with psoriasis and psoriatic arthritis, and also looks at how these conditions affect the heart. The goal is to find better ways to treat you and protect your heart health.
This study looks at how inflammation-related genes behave in people with psoriasis. It may help researchers understand why psoriasis flares and how it could be better treated.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
This study looks at health problems like heart disease and arthritis that are common in people with psoriasis. It aims to better understand these connections to improve care.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.